Hyaluronic
acid is a glycosaminoglycan polymer, which is commonly found in an
extracellular matrix of vertebrate epithelial, connective & neural tissues.
It plays a vital role in various signaling pathways in the human body for
instance wound healing, cancer treatment, embryonic development, and
inflammation. Its type & functioning depends upon the chain length or
molecular weight of the hyaluronic acid which is used in making the product.
High molecular weight hyaluronic acid is used in opthalmology, tissue
engineering, orthopedic products, and in the making of cosmetics, while low
molecular weight hyaluronic acid is employed in the production of substances
which induce expression of pro-inflammatory products & inhibit the tumor
progression in body. It is found to be ubiquitously spread in numerous parts of
vertebrate tissues with differing molecular weight & concentrations, which
includes brain, umbilical cord, and synovial fluid present between neural
tissues, rooster comb, joints, epithelium, and skin. It is processed either
from bacterium or rooster comb called ‘Streptococcus’.
According
to study, “World
Hyaluronic Acid Market Research Report 2024(covering USA, EU, China, South East
Asia, Japan and etc)” the key companies operating in the world
hyaluronic acid market are Q-Med, Lipo Chemicals, Abbott Medical Optics,
Stanford Chemicals, Anika Therapeutics, Allergan Inc., Novozymes, LG Life &
Science, Hyaltech, Medicis Aesthetics Holdings, Inc., Seikagaku, Shiseido,
CONTIPRO, Genzyme Biosurgery, Synvisc-One, Ferring Pharmaceuticals Inc., Sanofi,
Merz Pharmaceuticals, Paiho Group, Bausch+Lomb, Hao Hai Healthcare, Shanghai
Jingfeng, F.hoffmann-la Roche Ltd., Smith & Nephew Plc., Salix
Pharmaceuticals, Zimmer Biomet. Key companies are trying to collaborate with
universities & other research organizations for research activities, which
would lead them for high product innovations precise to the end-user
application and help them to increase the market by volume.
Based
on type, hyaluronic acid market is segmented into single injection type, three
injection type and five injection type. Single-injection segment is projected
to be the fastest-growing segment owing to high preference for short treatment
duration & quick results. Based on nature, market is segmented into
conventional nature and organic nature. Based on sales channel, market is
segmented into business to business (B2B) and business to customer (B2C). B2C
is further sub-segmented into hypermarket/supermarket, specialty stores and
online stores. Based on application, market is segmented into wound healing,
cushioning, eye-surgical operation, pain killer, moisturizers, anti-ageing
creams, lubrication, veterinary, sun protect, plastic-surgery injections,
dietary supplement and additive. In addition, based on end-use industries,
market is segmented into cosmetic industry, food industry, medical industry and
others.
The
hyaluronic acid market is driven by increase in skin & orthopedic problems
among the individuals, followed by rise in interest from beauty care products
& therapeutic application increase in disposable income, growth in use of
orthopedic products, rise in concern about toxic chemicals, increase in number
of cosmetic surgeries and rise in incidence of diseases, such as age-related
macular degeneration, glaucoma, cataracts, and dry eyes. However, cost-friendly
alternatives and allergic reactions caused owing to consumption of hyaluronic
acid may impact the market.
Based
on geography, the USA country holds major share, followed by EU in hyaluronic
acid market owing to quick adoption of new technologies & treatment methods
and high health awareness among individuals in the country. The China country
is expected to witness higher growth rate due to rise in geriatric population
and increase in awareness about aesthetic over the forecast period.
To
know more, click on the link below:-
Related
Reports:-
Contact
Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249